Evolution of the transdermal market: mergers, diversification, and business opportunities
Transdermal patches, those discreet allies we adhere to our skin to release drugs in a controlled manner, have come a long way since their introduction in 1979. While they have multiple advantages, they have not reached the market massively due to the significant challenges that a molecule must overcome to be administered by this route. To highlight this minority participation within the array of means to administer drugs to the body, we can mention that between 2015 and 2022, only 84 transdermal patches were approved out of a total of 7239 generic products by the FDA, representing just 1.2% of these products.
Fake Papers
In the 17th century, scientific work was disseminated through prestigious entities like academies or universities. Manuscripts were reviewed and published based on the institution members’ judgment. This method persisted until the 20th century when commercial publishers led to the emergence of Peer Review and the Journal Impact Factor (JIF). Open Access, which advocates for free access to scientific information, also became important. Despite facilitating scientific communication, these factors also led to problems like plagiarism and data fabrication.
The Future of Scientific Publishing
Scientific publishing faces evolution: from prestigious journals to commercial giants. Concerns arise over access barriers, rising costs, and the emergence of predatory publishers. The future hinges on open access and digitalization, shaping a dynamic landscape for knowledge exchange.
Sustainable Future in the Pharmaceutical Sector
Environmental sustainability is a fundamental pillar for maintaining a harmonious balance between humans and their natural environment. This implies creating programs that promote awareness of the environmental impact of our daily actions, as well as the products and services we consume.
Work-related accidents in the industry
Work-related accidents pose a constant concern in the industry, where the safety and well-being of employees are paramount. In this article, we will explore the crucial measures that must be implemented to prevent accidents, the responsibilities of companies, and the tools available to ensure a safe work environment.
Uniting forces for a healthy future
In the current crossroads of planetary challenges, the interrelation between the climate crisis and biodiversity loss serves as a wake-up call for humanity. These two seemingly distinct phenomena are intrinsically intertwined, and the failure to address them collectively poses significant risks to the sustainability of life on Earth.
Intestinal and brain connection: profound impact on neurodegenerative diseases
The growing prevalence of Alzheimer’s-type dementia, with over 35 million current cases and a projection to exceed 135 million by 2050, underscores the urgency of understanding and addressing challenges associated with neurodegenerative diseases.
Exploring Opportunities in Transmucosal Drug Administration: A Comprehensive Approach
Many companies, once focused solely on developing transdermal patches, are now also venturing into transmucosal forms, such as oral films.
Strategies to Deter Abuse in Transdermal Patches
According to the World Health Organization, the abusive consumption of certain drugs and substances has increased in recent years, resulting in serious consequences for the population, including neurological damage, motor disabilities, addiction, overdoses, and even death. While traditional pharmaceutical forms such as tablets are frequently abused, transdermal patches, especially those containing opioids, should also be considered.
How do we control the quality of transdermal patches?
Transdermal patches present certain attributes that make the efficacy, safety, and quality of the product and must be controlled in the laboratory through analytical techniques to ensure the performance and safety of the transdermal delivery system (or TDS). Some of them correspond to tests that are common to other pharmaceutical forms. However, due to the particular characteristics of transdermal patches, there are specific procedures that apply to TDSs and that are described in internationally recognized regulations and pharmacopoeias.